Neurologic manifestations of von Hippel-Lindau disease.
von Hippel-Lindau disease (VHL) is an autosomal-dominant neoplasia syndrome that is the result of a germline mutation of the VHL tumor suppressor gene on the short arm of chromosome 3. Patients with VHL are predisposed to develop lesions of the central nervous system and viscera. Central nervous system lesions include hemangioblastomas (the most common tumor in VHL) and endolymphatic sac tumors (ELSTs). Visceral manifestations include renal carcinomas and cysts, pancreatic neuroendocrine tumors and cysts, pheochromocytomas, and cystadenomas of the reproductive adnexal organs. Despite their benign pathology, hemangioblastomas and ELSTs are a frequent cause of morbidity and mortality in patients with VHL. Recent molecular biologic investigations into these VHL-associated central nervous system lesions provide new insight into their origin and development. Emerging data from serial imaging and clinical surveillance protocols provide insight into the natural history of these lesions. Because of the dissimilar pathobiology and clinical course between hemangioblastomas and ELSTs, the optimal management strategies for these neurologic manifestations of VHL are very different.
Butman
John A
JA
Diagnostic Radiology Department, The Clinical Center of the National Institutes of Health, Bethesda, Maryland 20892-1414, USA.
Linehan
W Marston
WM
Lonser
Russell R
RR
D000328:Adult; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D018450:Disease Progression; D004428:Ear Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D004712:Endolymphatic Sac; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000209:etiology; D018325:Hemangioblastoma / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000601:surgery; D010181:Pancreatic Cyst / Q000175:diagnosis / Q000209:etiology; D051794:Von Hippel-Lindau Tumor Suppressor Protein / Q000235:genetics; D006623:von Hippel-Lindau Disease / Q000150:complications* / Q000175:diagnosis*
D051794:Von Hippel-Lindau Tumor Suppressor Protein; C497446:VHL protein, human
Hum Mutat. 1998;12(6):417-23
9829911
J Neurosurg. 2008 Apr;108(4):751-6
18377255
J Med Genet. 1991 Jul;28(7):443-7
1895313
Ann Neurol. 2004 Feb;55(2):236-40
14755727
Otol Neurotol. 2004 Jul;25(4):599-603
15241241
J Neurosurg. 2003 Jan;98(1):95-105
12546357
N Engl J Med. 2004 Jun 10;350(24):2481-6
15190140
J Neurosurg Spine. 2006 May;4(5):426
16703915
Am J Med. 1964 Apr;36:595-617
14142412
Nature. 1998 Jul 30;394(6692):485-90
9697772
J Neurosurg. 2004 Mar;100(3):480-7
15035284
Nature. 1999 May 20;399(6733):271-5
10353251
Neuroradiology. 2000 Sep;42(9):639-42
11071434
Lancet. 2003 Jun 14;361(9374):2059-67
12814730
J Neurosurg. 2003 Jan;98(1):82-94
12546356
Radiology. 1995 Mar;194(3):629-42
7862955
Surgery. 2007 Dec;142(6):814-8; discussion 818.e1-2
18063061
Science. 1993 May 28;260(5112):1317-20
8493574
J Neurosurg. 2006 Aug;105(2):256-63
17219831
Neurology. 2000 Aug 8;55(3):460
10932304
Nature. 1988 Mar 17;332(6161):268-9
2894613
Am J Hum Genet. 1972 Sep;24(5):514-32
4340974
J Neurosurg. 2008 Feb;108(2):210-22
18240914
J Neurosurg. 2005 Mar;102(3):503-12
15796386
PLoS Med. 2007 Feb;4(2):e60
17298169
Medicine (Baltimore). 1989 Jan;68(1):1-29
2642584
JAMA. 2007 Jul 4;298(1):41-8
17609489
Hum Pathol. 1997 May;28(5):540-3
9158701
Development. 1998 Feb;125(4):725-32
9435292
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10589-94
8855222
J Intern Med. 1998 Jun;243(6):547-53
9681857
Cancer. 1989 Dec 1;64(11):2292-302
2804921
Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):493-9
8655372
Nature. 2004 Dec 2;432(7017):625-30
15577911
Ophthalmology. 2002 Sep;109(9):1745-51
12208726
J Neurosurg. 2006 Aug;105(2):248-55
17219830
Am J Ophthalmol. 2003 Jul;136(1):194-6
12834696
Am J Hum Genet. 2000 Jan;66(1):84-91
10631138
Am J Pathol. 1995 Aug;147(2):245-50
7639324
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2156-61
9122164
J Urol. 1999 Sep;162(3 Pt 1):659-64
10458336
Lancet. 1991 May 4;337(8749):1052-4
1673491
Cancer Res. 2005 Dec 1;65(23):10847-53
16322231
Brain. 2007 Mar;130(Pt 3):836-42
17264095
Arch Neurol. 1976 Jun;33(6):435-41
945725
J Neurosurg. 1996 Oct;85(4):591-6
8814161
JAMA. 1997 May 14;277(18):1461-6
9145719
J Urol. 1999 May;161(5):1475-9
10210376
Mol Cell. 1998 Jun;1(7):959-68
9651579
Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6459-63
7604013
J Neurosurg. 2003 Jan;98(1):106-16
12546358
Cancer Res. 2006 Apr 15;66(8):4167-72
16618738
Nat Rev Cancer. 2002 Sep;2(9):673-82
12209156
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):993-8
9448273
Otol Neurotol. 2002 May;23(3):378-87
11981399